Predictive values of baseline 18F-FDG PET/CT for toxicities and outcomes in patients with relapsed or refractory multiple myeloma following BCMA CAR T-cell therapy
Year: 2025
Type: article
Language: en
Topic: CAR-T cell therapy research
Authors and affiliations:
raw_author_name: Pingnan Xiao
raw_affiliation_strings: Bone Marrow Transplantation Center, the First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
Institute of Hematology, Zhejiang University, Hangzhou, China
Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China
raw_author_name: Xin Zhao
raw_affiliation_strings: Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
raw_author_name: Linqin Wang
raw_affiliation_strings: Bone Marrow Transplantation Center, the First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
Institute of Hematology, Zhejiang University, Hangzhou, China
raw_author_name: Kanfeng Liu
raw_affiliation_strings: Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
raw_author_name: Yixue Li
raw_affiliation_strings: Bone Marrow Transplantation Center, the First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
Institute of Hematology, Zhejiang University, Hangzhou, China
raw_author_name: Mingming Zhang
raw_affiliation_strings: Bone Marrow Transplantation Center, the First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
Institute of Hematology, Zhejiang University, Hangzhou, China
Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China
raw_author_name: Yafei Zhang
raw_affiliation_strings: Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
Shanghai YaKe Biotechnology Ltd, Shanghai, China
raw_author_name: Yinuo Liu
raw_affiliation_strings: Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
raw_author_name: Jingjing Feng
raw_affiliation_strings: Bone Marrow Transplantation Center, the First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
Institute of Hematology, Zhejiang University, Hangzhou, China
Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China
raw_author_name: Ruimin Hong
raw_affiliation_strings: Bone Marrow Transplantation Center, the First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
Institute of Hematology, Zhejiang University, Hangzhou, China
Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China
raw_author_name: Shan Fu
raw_affiliation_strings: Bone Marrow Transplantation Center, the First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
Institute of Hematology, Zhejiang University, Hangzhou, China
Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China
raw_author_name: Houli Zhao
raw_affiliation_strings: Bone Marrow Transplantation Center, the First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
Institute of Hematology, Zhejiang University, Hangzhou, China
Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China
raw_author_name: Jiazhen Cui
raw_affiliation_strings: Bone Marrow Transplantation Center, the First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
Institute of Hematology, Zhejiang University, Hangzhou, China
Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China
raw_author_name: Huijun Xu
raw_affiliation_strings: Bone Marrow Transplantation Center, the First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
Institute of Hematology, Zhejiang University, Hangzhou, China
Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China
raw_author_name: Xiaoyu Wu
raw_affiliation_strings: Bone Marrow Transplantation Center, the First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
Institute of Hematology, Zhejiang University, Hangzhou, China
Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China
raw_author_name: Yanlei Zhang
raw_affiliation_strings: Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
Shanghai YaKe Biotechnology Ltd, Shanghai, China
raw_author_name: Guoqing Wei
raw_affiliation_strings: Bone Marrow Transplantation Center, the First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
Institute of Hematology, Zhejiang University, Hangzhou, China
Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China
raw_author_name: Alex Hongsheng Chang
raw_affiliation_strings: Engineering Research Center of Gene Technology, Ministry of Education, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, China
Shanghai YaKe Biotechnology Ltd, Shanghai, China
raw_author_name: Kui Zhao
raw_affiliation_strings: Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
raw_author_name: He Huang
raw_affiliation_strings: Bone Marrow Transplantation Center, the First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
Institute of Hematology, Zhejiang University, Hangzhou, China
Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China
raw_author_name: Yongxian Hu
raw_affiliation_strings: Bone Marrow Transplantation Center, the First Affiliated Hospital, and Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China. 1313016@zju.edu.cn
Institute of Hematology, Zhejiang University, Hangzhou, China. 1313016@zju.edu.cn
Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China. 1313016@zju.edu.cn